Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F55WP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,343
Award facts
- Contract value 100% obligated
- $41,342.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,342.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on November 4, 2025, with a completion date of November 5, 2025. This non-competitive delivery order, issued without a set-aside designation, draws from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The work will be performed at the company's corporate office location in Conshohocken, PA.
This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's expansive prime vendor agreement with DLA, which enables the company to supply a diverse range of medications, vaccines, and medical supplies to support military healthcare programs globally. Dupixent is a biologic medication used to treat moderate-to-severe eczema, asthma, and other allergic conditions, indicating this shipment supports the medical needs of the Defense Health Agency and other federal health systems served through the DLA supply chain. The award reflects AmerisourceBergen's established capability and performance as a primary supplier within the federal pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DR26F55WP?
SPE2DR26F55WP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26F55WP worth?
The government has obligated $41,343 on SPE2DR26F55WP.
Is contract SPE2DR26F55WP an order under another contract?
Yes. SPE2DR26F55WP is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F55WP competed?
The extent of competition for SPE2DR26F55WP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award